Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SBFM
↓ PDF (Pro)Sunshine Biopharma Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ
$1.09
-1.36%today
MKT CAP
$5M
+10.1% · 1Y
Earnings History
-
-254.6%
-46.2%
-70.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$1.09
Low
$5.60
Analyst Mean
$5.60
High
$5.60
1 analystNone
Full Financials
Trailing P/E-
Forward P/E0.0x
EV/EBITDA0.8x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-10.6%
Earnings Growth YoY-
Revenue Growth QoQ-8.9%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin33.8%
Operating Margin-19.3%
Net Margin-16.5%
ROE-25.7%
Debt / Equity3.53x
Free Cash Flow$-4,632,801
Insider Ownership0.0%
Institutional Ownership5.4%
Short % of Float2.74%
Days to Cover4.0d
1 Week+12.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NATAN DAVID | Director | Stock | 100,000 | $0.00 | $0.00M | 2026-04-14 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Citadel Advisors Llc | institution | 1.10% | $0.00B | -30.94% | 2025-12-31 |
| Virtu Financial LLC | institution | 0.48% | $0.00B | +100.00% | 2025-12-31 |
| Xtx Topco Ltd | institution | 0.33% | $0.00B | +100.00% | 2025-12-31 |
| Morgan Stanley | institution | 0.30% | $0.00B | +281.69% | 2025-12-31 |
| Commonwealth Equity Services, LLC | institution | 0.27% | $0.00B | +100.00% | 2026-03-31 |
| SBI Securities Co., Ltd. | institution | 0.04% | $0.00B | -62.17% | 2026-03-31 |
| UBS Group AG | institution | 0.02% | $0.00B | -41.11% | 2026-03-31 |
| Osaic Holdings Inc. | institution | 0.00% | $0.00B | +0.00% | 2025-12-31 |
| National Bank of Canada/FI/ | institution | 0.00% | $0.00B | +0.00% | 2025-12-31 |
| Bank of America Corporation | institution | 0.00% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity NASDAQ Composite Index Fund | fund | 0.00% | $0.00B | -94.55% | 2024-08-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| BIOA | $820M | - | - | - | - | -27.1% | 0% | 2.04 | 0.00% |
| ETON | $833M | 60 | - | 16.4 | - | - | - | - | 0.00% |
| PCRX | $937M | 58 | 193.0 | 7.0 | - | - | - | - | 0.00% |
| CRON | $990M | 5 | - | - | - | - | - | - | 0.00% |
| AMPH | $1.1B | 100 | 11.8 | 6.9 | - | - | - | - | 0.00% |
| XERS | $1.1B | 60 | 94.7 | 17.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SBFM.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.